Advertisement
Screener

Collegium Pharmaceutical, Inc. (COLL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Collegium Pharmaceutical, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Collegium Pharmaceutical, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $329.32M came in.
  • Fiscal year ended 2025-12-31: from investing, $63.53M went out.
  • Fiscal year ended 2025-12-31: from financing, $110.25M went out.
  • Fiscal year ended 2025-12-31: change in cash, $155.55M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31$329.32M-$63.53M-$25.10M$565.17M-$12.85M$4.28M-$641.75M*$155.55M
2024-12-31$204.98M-$287.76M-$60.02M$0.00-$19.17M$10.25M$8.35M*-$143.38M
2023-12-31$274.75M-$70.81M-$75.00M$0.00-$8.36M$8.64M-$65.46M*$63.76M
2022-12-31$124.23M-$573.69M-$14.06M-$4.04M$11.81M$443.02M*-$12.74M
2021-12-31$103.56M-$1.94M-$47.86M-$4.15M$11.95M-$49.24M*$12.31M
2020-12-31$93.94M-$373.77M-$11.50M-$2.25M$6.58M$293.65M*$6.64M
2019-12-31$27.78M-$6.44M-$822.00K*$2.05M$23.39M
2018-12-31$169.39M-$24.35M$10.02M-$560.00K-$30.00K-$126.63M*$27.84M
2017-12-31-$67.02M-$990.00K-$2.67M-$68.00K$34.34M$1.88M*-$34.53M
2016-12-31-$75.05M-$2.98M-$2.67M$137.34M$885.00K*$57.53M
2015-12-31-$21.57M-$362.00K-$1.29M$72.03M$45.25M*$94.06M
2014-12-31-$17.95M-$8.00K$72.00K$11.97M*
2013-12-31-$16.53M-$206.00K$1.00K$12.35M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30$71.32M*-$502.59M*$0.00-$646.00K*$481.00K*$292.25M*
2026-03-31$57.11M$1.63M-$15.43M$394.00K-$6.30M*$37.40M
2025-12-31$123.05M*-$20.07M*$0.00*-$861.00K*$985.00K*-$21.95M*
2025-09-30$78.44M*-$30.87M*$0.00*-$964.00K*$1.44M*-$15.29M*
2025-06-30$72.44M*-$2.92M*-$25.10M-$428.00K*$308.00K*-$23.15M*
2025-03-31$55.40M-$9.68M-$10.59M$1.55M-$16.20M*$20.48M
2024-12-31$84.64M*-$11.76M*-$25.02M*-$279.00K*$173.00K*-$16.15M*
2024-09-30-$9.00M*-$248.96M*$0.00*-$142.00K*$149.00K*$149.02M*
2024-06-30$67.40M*-$8.91M*-$5.88M*$5.72M*-$114.05M*
2024-03-31$61.94M-$18.13M-$12.87M$4.21M-$45.48M*-$10.34M
2023-12-31$73.34M*-$25.10M*-$25.00M*-$233.00K*$3.24M*-$45.83M*
2023-09-30$74.02M*-$3.82M*-$172.00K*$302.00K*-$95.54M*
2023-06-30$99.72M*-$41.72M*-$220.00K*$1.25M*-$46.27M*
2023-03-31$27.67M-$176.00K-$7.74M$3.85M$72.19M*$95.79M
2022-12-31$66.33M*-$940.00K*-$7.64M*-$45.00K*$6.86M*-$25.00M*
2022-09-30$42.77M*-$113.00K*-$106.00K*$142.00K*-$31.29M*
2022-06-30$40.45M*-$461.00K*-$511.00K*$1.54M*-$25.00M*
2022-03-31-$25.32M-$572.18M-$3.38M$3.26M$517.88M*-$79.73M
2021-12-31$36.20M*-$515.00K*-$32.34M*$0.00*$2.34M*-$12.50M*
2021-09-30$17.25M*-$276.00K*-$220.00K*$1.34M*-$27.63M*
2021-06-30$29.54M*-$725.00K*-$421.00K*$4.09M*-$12.50M*
2021-03-31$20.57M-$428.00K-$3.51M$4.18M-$12.14M*$8.67M
2020-12-31$22.58M*-$1.48M*$0.00*-$86.00K*$183.00K*-$12.50M*
2020-09-30$34.18M*-$2.40M*$0.00*-$247.00K*$314.00K*-$12.10M*
2020-06-30$43.85M*-$2.24M*$0.00*-$564.00K*$1.63M*-$13.27M*
2020-03-31-$6.67M-$367.65M-$11.50M-$1.36M$4.45M$331.52M*-$51.20M
2019-12-31$15.66M*-$889.00K*-$101.00K*$1.51M*
2019-09-30$6.07M*-$1.35M*-$198.00K*$232.00K*
2019-06-30$14.63M*-$875.00K*-$35.00K*$86.00K*
2019-03-31-$8.57M-$3.32M-$488.00K$213.00K-$11.72M
2018-12-31$42.29M*-$1.77M*$0.00*-$90.00K*$168.00K*-$33.75M*
2018-09-30$41.83M*-$2.72M*$1.00K*-$114.00K*$182.00K*-$33.14M*
2018-06-30$55.60M*-$747.00K*$0.00*-$140.00K*$1.53M*-$51.45M*
2018-03-31$29.66M-$19.12M$10.02M-$216.00K$2.37M-$12.56M*$10.16M
2017-12-31-$13.30M*-$172.00K*-$667.00K*$0.00*$24.91M*
2017-09-30-$12.57M*-$340.00K*-$667.00K*-$17.00K*$13.00K*$9.98M*
2017-06-30-$17.47M*-$449.00K*-$667.00K*$0.00*$321.00K*
2017-03-31-$23.69M-$29.00K-$666.00K*-$51.00K$94.00K-$23.67M
2016-12-31-$23.29M*-$341.00K*-$667.00K*$85.72M*
2016-09-30-$19.41M*-$111.00K*-$667.00K*$445.00K*
2016-06-30-$20.84M*-$666.00K*$0.00*
2016-03-31-$11.52M-$667.00K$51.17M
2015-12-31-$8.94M*-$187.00K*$0.00*-$637.00K*
2015-09-30-$6.54M*-$152.00K*$1.00K*
2015-06-30-$4.41M*$11.00K*$71.85M*
2015-03-31-$1.68M$460.00K$44.58M*
2014-12-31-$7.57M*$63.00K*$4.97M*
2014-09-30-$4.41M*$8.00K*$5.99M*
2014-06-30-$2.20M*$0.00*
2014-03-31-$3.77M$1.00K$1.03M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
GERON CORP (GERN)United States$0.803B-12.14